India's Camlin Fine Sciences hits nearly 4-year high after Q4 profit surge

Camlin Fine Sciences

26/05/2025 09:28

** Camlin Fine Sciences CAMF.NS surges 16.2% to 218 rupees, highest since July 2021

** Specialty chemicals maker's Q4 consol pre-tax profit soars more than 300% y/y, helped by revenue growth in aroma ingredients segment; rev rises 16%

** Net loss after adjusting for taxes, exceptional items and losses from discontinued ops plunges 99% y/y

** PhillipCapital ("buy;" PT 255 rupees): Co poised for strong, profitable growth as it exits loss-making EU/China ops, gains from anti-dumping duties on Chinese vanillin from July 2025, integrates recent Blends acquisitions, consolidates manufacturing within India

** Around 11 mln shares traded, more than 7x the 30-day avg

** YTD, CAMF gains 71%

 (Reporting by Aleef Jahan in Bengaluru)

 ((aleefjahan.cs@thomsonreuters.com))